Category Archives: HIV care & treatment

IAS-2013: Number of HIV regimens tied to low bone density

post_ias2013

by Mark Mascolini, National AIDS Treatment Advocacy Project 7th International AIDS Society Conference, Kuala Lumpur, June 2013: Each additional antiretroviral therapy (ART) regimen taken was independently associated with 0.011 g/cm(2) lower femoral neck bone mineral density (BMD) and 0.015 g/cm(2) lower lumbar spine BMD in a…Read More

IAS2013: BIT225 reduces HIV reservoirs

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: Though most studies of HIV eradication have focused on CD4+ T cells, a new study of a therapy called BIT225 has found a reduction in HIV levels in monocyte cells, which help replenish the architecture of lymph…Read More

IAS2013: American HIV treatment Guidelines get it right

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: United States antiretroviral treatment guidelines for adolescents and adults from the US Public Health Service apparently get it right in terms of the regimens the document deems preferred for first line therapy. Such regimens were more effective…Read More

IAS2013: Very long acting treatment (1 dose per month) is moderately well tolerated

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: A new study combining a once-monthly dose of a nan-oparticle formulation of a new integrase inhibitor called GSK-744 with a once-monthly NNRTI called TMC-278 was largely well tolerated in healthy HIV-negative people over 134 days. The study is looking at…Read More

IAS2013: Study offers more details on people who control HIV after stopping ARVs

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: In November 2012 and March 2013, researchers in France reported on 14 HIV-positive individuals who had gone on HIV therapy in early infection and then eventually stopped treatment, without a lasting rebound of the virus. Such individuals,…Read More

IAS2013: Switching to etravirine (Intelence) improves levels of blood fats

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: For HIV-positive people currently on treatment who may need help with better controlling their blood fat levels, switching to the NNRTI etravirine (Intelence) may offer them an option. A retrospective British study followed 389 people between 2008–2012…Read More

IAS2013: Intimate partner violence changes how men who have sex with men use condoms

post_ias2013

by Mark Mascolini, National AIDS Treatment Advocacy Project 7th International AIDS Society Conference, Kuala Lumpur, June 2013: Almost half of 745 men who have sex with men (MSM) studied in the Atlanta area reported being a victim of intimate male partner violence [1]. Experiencing such violence…Read More